
TENOFOVIR 300 mg + LAMIVUDINE 300 mg + EFAVIRENZ 600 mg (Telura) is a prescription fixed-dose combination antiretroviral medicine used to treat human immunodeficiency virus type 1 (HIV-1) infection. It combines three antiviral medicines that work together to suppress HIV replication, reduce the viral load, and help maintain immune-system function. It is used as part of long-term HIV treatment under the supervision of a healthcare provider.
| Generic name | TENOFOVIR/LAMIVUDINE/EFAVIRENZ |
| Strength | 300 mg + 300 mg + 600 mg |
| Manufacturer | Mylan |
| Package size | 30 Tablets |
| Used for | (HIV-1) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Tenofovir, lamivudine, and efavirenz work together to block HIV replication. Tenofovir and lamivudine are nucleoside and nucleotide reverse transcriptase inhibitors that prevent the virus from copying its genetic material. Efavirenz is a non-nucleoside reverse transcriptase inhibitor that binds to the same enzyme at a different site and further disrupts viral replication. Together, these medicines reduce the amount of HIV in the body and help protect the immune system.